Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $1, expectations were $0.75.
Source: insidermonkey.com
Stay updated with breaking news from Eli Kalif. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $1, expectations were $0.75.
TEVA earnings call for the period ending December 31, 2023.
TEVA earnings call for the period ending December 31, 2023.
Operator: Hello, and welcome to the Q3 2023 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today.
TEVA earnings call for the period ending September 30, 2023.